Floatz logo

LEUPROLIDE

Obesity, Morbid

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinsprotein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

42 Active assets in the Obesity, Morbid cohort.

Asset / SponsorPhaseRating
Liraglutide
University of Sao Paulo General Hospital
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Tanta University
Phase 4BB
Semaglutide
Zuyderland Medisch Centrum
Phase 4BB
DEXKETOPROFEN
Kirsehir Ahi Evran Universitesi
Phase 4BB
CHLORHEXIDINE
University of Taubate
Phase 4BB

View all 50 →

Same molecule, other indications

LEUPROLIDE is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →